A prospective cohort study to assess the effectiveness of the BNT162b2 vaccine and to examine possible correlates of protection and infectivity among health care workers in Israel
Latest Information Update: 15 Oct 2021
Price :
$35 *
At a glance
- Drugs Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics; Therapeutic Use
- 06 Oct 2021 Results published in the New England Journal of Medicine
- 15 Sep 2021 New trial record
- 28 Jul 2021 Results published in the New England Journal of Medicine